You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 11,013,703


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,013,703 protect, and when does it expire?

Patent 11,013,703 protects SOTYLIZE and is included in one NDA.

This patent has one patent family member in one country.

Summary for Patent: 11,013,703
Title:Sotalol compositions and uses of the same
Abstract: The present invention provides oral solutions containing sotalol hydrochloride which advantageously avoid swallowing while providing with improved stability. The present invention also relates to methods of using the oral solutions for treatment of diseases and disorders, such as delay in reoccurrence of atrial fibrillation/atrial flutter and/or ventricular arrhythmias.
Inventor(s): Thomas; H. Greg (Carrollton, GA), Kiel; Jeffrey S. (Gainesville, GA)
Assignee: Arbor Pharmaceuticals, LLC (Atlanta, GA)
Application Number:16/243,440
Patent Claim Types:
see list of patent claims
Composition; Formulation; Compound;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 11,013,703

Introduction

United States Patent 11,013,703, titled "Sotalol compositions and uses of the same," is a patent that focuses on oral solutions containing sotalol hydrochloride. This patent is crucial for pharmaceutical companies and researchers working on cardiac medications. Here, we will delve into the details of the patent's scope, claims, and the broader patent landscape.

Patent Overview

The patent US 11,013,703 B2 describes oral solutions of sotalol hydrochloride, a medication used to treat certain heart rhythm disorders. The invention aims to provide formulations that avoid the need for swallowing, enhancing patient compliance and stability of the medication[4].

Scope of the Patent

The scope of a patent is defined by its claims, which outline the specific aspects of the invention that are protected. For US 11,013,703, the scope includes:

  • Oral Solutions: The patent covers specific formulations of sotalol hydrochloride designed for oral administration without the need for swallowing.
  • Stability: The invention emphasizes improved stability of the sotalol hydrochloride in the oral solution, which is a critical factor for pharmaceutical efficacy and safety.
  • Patient Compliance: By avoiding the need for swallowing, the patent addresses a significant issue in patient compliance, particularly for patients with difficulty swallowing[4].

Claims Analysis

The claims of a patent are the legal boundaries that define what is protected. Here are some key points to consider:

Independent Claims

Independent claims stand alone and do not depend on other claims. They define the broadest scope of the invention.

  • For US 11,013,703, independent claims would likely include the composition of the oral solution, the method of preparation, and the specific benefits such as improved stability and patient compliance.

Dependent Claims

Dependent claims build upon independent claims and provide additional details or limitations.

  • Dependent claims might include specific concentrations of sotalol hydrochloride, additional ingredients, or particular methods of administration that enhance the stability or efficacy of the oral solution.

Claim Fees and Strategy

When filing a patent application, the number and type of claims can impact the fees incurred. In the US, claim fees are charged for each claim in excess of 20, each independent claim in excess of 3, and for multiple dependent claims. To avoid these fees, applicants often strategize to keep the number of claims within the free limits[5].

Inventorship Determination

Determining the correct inventors is crucial for the validity and enforceability of a patent. According to US patent law, an inventor is someone who conceives the subject matter of at least one claim of the patent. This conception must be a "definite and permanent idea" that can be reduced to practice without extensive research or experimentation[1].

Patent Landscape and Trends

The patent landscape for pharmaceuticals, particularly those related to cardiac medications, is highly competitive and dynamic.

Patent Scope Metrics

Research on patent scope, such as the work by Marco, Sarnoff, and deGrazia, highlights the importance of metrics like independent claim length and independent claim count in measuring patent scope. These metrics can indicate the breadth and clarity of the patent claims, which are critical in the pharmaceutical industry[3].

Examination Process

The examination process for patents tends to narrow the scope of claims, making them more specific and less broad. This process is essential for ensuring that patents are granted for novel and non-obvious inventions, which in turn encourages innovation[3].

Economic and Legal Implications

The economic and legal implications of a patent like US 11,013,703 are significant.

Patent Maintenance and Licensing

Patents with clear and narrow claims are more likely to be maintained and licensed effectively. Broad or overly vague claims can lead to increased licensing and litigation costs, which can diminish the incentives for innovation[3].

Enforceability

Correct inventorship and accurate claim drafting are essential for the enforceability of a patent. Errors or deceptive intent in naming inventors can render a patent unenforceable, even if the correct inventorship can be established later[1].

Examples and Case Studies

  • Hess v. Advanced Cardiovascular Systems: This case illustrates the importance of distinguishing between conception and reduction to practice. An engineer who suggested materials and explained their properties was not considered an inventor because his contributions were based on well-known principles and did not add novel or non-obvious elements to the invention[1].

Statistics and Data

The USPTO's Patent Claims Research Dataset provides detailed information on claims from US patents and applications. This dataset can be used to analyze trends in patent scope and claim characteristics, which are valuable for understanding the broader patent landscape[2].

Key Takeaways

  • Scope and Claims: The patent's scope is defined by its claims, which must be clear, specific, and novel.
  • Inventorship: Correct identification of inventors is crucial for the patent's validity and enforceability.
  • Patent Landscape: The pharmaceutical patent landscape is competitive, with a focus on clear and narrow claims to ensure innovation and enforceability.
  • Economic Implications: Clear and specific claims can reduce licensing and litigation costs, promoting innovation.

FAQs

Q: What is the main focus of US Patent 11,013,703? A: The main focus is on oral solutions containing sotalol hydrochloride, designed to avoid swallowing and improve stability.

Q: How are claim fees calculated in the US? A: Claim fees are charged for each claim in excess of 20, each independent claim in excess of 3, and for multiple dependent claims.

Q: Why is correct inventorship important? A: Correct inventorship is essential for the validity and enforceability of a patent, as errors or deceptive intent can render the patent unenforceable.

Q: What metrics are used to measure patent scope? A: Metrics such as independent claim length and independent claim count are used to measure patent scope and indicate the breadth and clarity of the claims.

Q: How does the examination process affect patent claims? A: The examination process tends to narrow the scope of patent claims, making them more specific and less broad to ensure they are novel and non-obvious.

Cited Sources

  1. Determining Inventorship for US Patent Applications - Oregon State University.
  2. Patent Claims Research Dataset - USPTO.
  3. Patent Claims and Patent Scope - SSRN.
  4. US11013703B2 - Sotalol compositions and uses of the same - Google Patents.
  5. Claim fees: how to avoid their payment? - Plass.com.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 11,013,703

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Azurity SOTYLIZE sotalol hydrochloride SOLUTION;ORAL 205108-001 Oct 22, 2014 RX Yes Yes 11,013,703 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 11,013,703

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
World Intellectual Property Organization (WIPO) 2015153762 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.